Molecule Details
| InChIKey | AZQFCMJDNRLROF-QHCPKHFHSA-N |
|---|---|
| Compound Name | N-[(1R)-1-(2,4-dichlorophenyl)-2-imidazol-1-ylethyl]-4-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]benzamide |
| Canonical SMILES | O=C(N[C@@H](Cn1ccnc1)c1ccc(Cl)cc1Cl)c1ccc(-c2nnc(-c3ccc(F)c(F)c3)o2)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.07 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| A2TEF2 | Leishmania infantum | Pathogen | PF00067 | 8.8 | Kd | ChEMBL;BindingDB | |
| Q7Z1V1 | CYP51 | Trypanosoma cruzi (strain CL Brener) | Pathogen | PF00067 | 8.4 | Kd | ChEMBL;BindingDB |
| P10613 | ERG11 | Candida albicans (strain SC5314 / ATCC MYA-2876) | Pathogen | PF00067 | 7.9 | Kd | ChEMBL;BindingDB |
| G4WW85 | cyp51A | Aspergillus niger | Pathogen | PF00067 | 7.2 | Kd | ChEMBL |